Biotech

All Articles

Amgen documents first stage 3 gain for $400M dermatitis medication

.Amgen has discussed (PDF) the initial period 3 records on its own $400 million eczema medication, l...

Biogen, UCB document stage 3 lupus gain after neglecting earlier test

.Biogen and also UCB's depend advancing into stage 3 astride a failed research wants to have repaid,...

Aptadir wishes brand new RNA preventions can turn around tricky cancers cells

.Italian biotech Aptadir Rehabs has actually introduced along with the guarantee that its pipe of pr...

Wave surfs DMD excellence to regulatory authorities' doors, sending stock up

.Surge Lifestyle Sciences has actually fulfilled its goal in a Duchenne muscular dystrophy (DMD) res...

Sanofi plucks brand new CSO from in-stealth biotech

.After a few years in biotech, Mike Quigley, Ph.D., is coming back to the pharma layer, occupying th...

Achilles droplets tissue therapy plan, supports for cutbacks after skipping 'commercial viability' objectives

.Achilles Rehabs has destroyed its own approach. The British biotech is knocking off on its clinical...

Aligos advertises phase 2 MASH gain, reducing liver body fat as much as 46%

.Aligos Therapies is advertising a midstage succeed in metabolic-dysfunction linked steatohepatitis ...

Basilea ratings $268M BARDA funding for antifungals, anti-biotics

.Basilea Pharmaceutica's work developing brand-new antifungals has actually obtained a significant b...

Capricor offers Europe rights to late-stage DMD therapy for $35M

.Possessing presently gathered up the united state rights to Capricor Therapeutics' late-stage Duche...

FDA junks adcomm for Applied's unusual disease drug

.After dismissing the choice date for Applied Therapeutics' metabolic ailment medication govorestat,...